 * *IRI* = http://purl.obolibrary.org/obo/UBERON_0000456
 * *Label* = bodily secretion
 * *Definition* = Body substance in a liquid or semisolid state produced by an exocrine gland. Example: saliva, sebum, blood, plasma, semen, urine.
 * *Comment* = AO notes: BTO has two distunct classes, with exocrine glandular secretion a subtype of secretion - however, all examples in BTO directly under secretion appear to be exocrine gland secretions

## Synonyms

 * exocrine gland fluid/secretion
 * secreted substance
 * exocrine gland fluid
 * exocrine gland fluid or secretion
 * exocrine gland secretion
 * external secretion
 * secretion

## Superclasses

 * [portion of organism substance](../../UBERON/63/UBERON_0000463.md)
 * [produced_by](../../RO/01/RO_0003001.md) some [exocrine gland](../../UBERON/65/UBERON_0002365.md)

## Equivalencies

 * ObjectIntersectionOf(<http://purl.obolibrary.org/obo/UBERON_0000463> ObjectSomeValuesFrom(<http://purl.obolibrary.org/obo/RO_0003001> <http://purl.obolibrary.org/obo/UBERON_0002365>))

## Other Logical Axioms


## Other Annotations

 * *[has_alternative_id](../../Id/oboInOwl#hasAlternativeId.md)* = UBERON:0006540
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = AEO:0001005
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = BTO:0002977
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = BTO:0002979
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = FMA:9675
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = MA:0002504
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = MESH:A12.200
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = UMLS:C1516992
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = galen:Secretion
 * *[database_cross_reference](../../ef/oboInOwl#hasDbXref.md)* = ncithesaurus:Exocrine_Gland_Fluid_or_Secretion
 * *[has_obo_namespace](../../ce/oboInOwl#hasOBONamespace.md)* = uberon
 * *[oboInOwl#id](../../id/oboInOwl#id.md)* = UBERON:0000456

## External Comments

